The data presented here demonstrates that modulation of heparan sulfate synthesis has the capacity to rescue cell loss in two models of human neurodegenerative diseases, one mediated by overexpression of Presenilin and the other by loss of parkin function. The gene discussed is PRKN; the disease is neurodegenerative disease.